Mirror therapy stroke rehabilitation using an immersive virtual reality headset with people who have a weakness or impairment in one of their hands

Not Applicable

Completed

• Conditions: Rehabilitation following stroke (ischaemic and haemorrhagic); Circulatory System; Stroke, not specified as haemorrhage or infarction

• Registration Number: ISRCTN34011164
• Lead Sponsor: niversity of Otago

Brief Summary

2022 Results article in https://pubmed.ncbi.nlm.nih.gov/36207720/ (added 10/10/2022)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2020-01-17
• Study Start: 2021-12-03
• Last Update Posted: 24 October 2022

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 11

Inclusion Criteria

1. Aged at least 18 years
2. Suffered a first-time stroke
3. Has a severe, one-sided paresis of the hand

Exclusion Criteria

1. Severe cognitive or emotional limitations
2. Insufficient seat-sitting stability
3. Severe speech comprehension or speech production deficit
4. Simultaneous participation in another study

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<br> 1. Adherence assessed using the BeST documentation after first, second and third intervention<br> 2. Rehabilitation dose assessed using the BeST documentation after first, second and third intervention<br> 3. Protocol progress assessed using the BeST documentation after first, second and third intervention<br> 4. Safety assessed using the Simulator Sickness questionnaire and VR Adverse Event Monitoring questionnaire after first, second and third intervention<br> 5. Affected Hand Function assessed using the Fugl-Meyer UE subset (Part B + C) during the pre- and post-assessments<br>

Secondary Outcome Measures

Name	Time	Method
<br> 1. Perceptions regarding immersive VR intervention by person with stroke measured using the VR Acceptance, Motivation, and Self-Evaluation questionnaire after the first and third intervention<br> 2. Tingling/paraesthesia occurrences determined by BeST documentation during the first, second and third interventions<br> 3. User experience measured using the meCUE 2.0 questionnaire after the third intervention<br>